The team behind the science
Combined expertise spanning nuclear medicine, pharmaceutical sciences, drug delivery, and clinical trial management.
Prof. Christene Leiper
Professor Christene Leiper is Co-Founder and Director of Med eTech Innovation Ltd, Co-Founder of Onorach Innovation, and a Senior Associate of the Royal Society of Medicine. Her career spans more than 40 years across clinical research, nuclear medicine, drug development, stroke care and healthcare innovation.
She was the first woman in Australia to validate the Technegas Easy Breather Accessory (TEBA) for ventilated intensive care patients and conducted pioneering pulmonary imaging research in collaboration with international experts. In Scotland she played a key role in establishing the Scottish Stroke Care Audit, helping drive improvements in stroke services and patient outcomes nationwide.
Professor Leiper has founded and led international contract research organisations supporting Phase I to Phase IV clinical trials, medical devices and digital health innovation. She continues to champion patient-centred clinical research, digital consent technologies, ethical innovation and global collaboration in healthcare.
Stephen Leiper
Stephen Leiper is Co-Founder, Director and CEO of Med eTech Innovation and CEO of Onorach Innovation. A fully qualified histologist, he has more than 30 years' experience in diagnostics and molecular research, spanning diagnostic product sales, molecular research tools and clinical research technologies for some of the world's largest molecular research companies.
He co-led the Clinical Trial domain of PharmaLedger with UCB, co-leading the eConsent use case with Boehringer Ingelheim and the Clinical Trial Recruitment use case with Pfizer, and went on to lead eConsent in the PharmaLedger spinout. PharmaLedger was a Horizon 2020 programme funded by the Innovative Medicines Initiative and EFPIA, uniting 12 global pharmaceutical companies to build a trusted blockchain platform for healthcare. Onorach Innovation's eConsent package builds directly on the intellectual property developed in the consortium and is being developed for Med eTech's dDIB digital services.
Stephen is President of the International Biodiscovery Forum, where he speaks on digital health and eConsent.
Dr. Kishor Wasan
Dr. Kishor Wasan is a Canadian pharmacologist, pharmacist and academic leader recognised for research in lipid-based drug delivery and global health. He has published more than 550 peer-reviewed articles and abstracts and is co-inventor of a novel oral amphotericin B formulation for systemic fungal and parasitic infections. He serves as Chief Scientific Officer of Med eTech Innovation Ltd.
Current appointments include Distinguished University Scholar and Adjunct Professor, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, and Co-Founder and Co-Director of the Neglected Global Diseases Initiative at UBC. He previously served as Associate Dean of Research and Graduate Studies at UBC and Dean of the College of Pharmacy and Nutrition at the University of Saskatchewan.
Dr. Wasan is a Fellow of the Canadian Academy of Health Sciences, the American Association of Pharmaceutical Scientists, the Canadian Society for Pharmaceutical Sciences and the Royal Society of Medicine. In 2025 he received both the MD Anderson Cancer Center Distinguished Alumnus Award and the Canadian Society for Pharmaceutical Sciences Lifetime Achievement Award.